CVS Caremark Newswire (Page 4)

Comprehensive Real-Time News Feed for CVS Caremark. (Page 4)

Results 61 - 80 of 247 in CVS Caremark

  1. Assessing Gilead's Reality-Perception Gap: Upside Revenue SurpriseRead the original story w/Photo

    Jan 6, 2015 | Seeking Alpha

    AbbVie announced a deal with Express Scripts that has had a major impact on GILD's share price. CVS announced Monday it would make Gilead's hepatitis C pills the exclusive treatment option for beneficiaries on its Medicare, Medicaid and other drug benefit plans.


  2. Pharmacy giant CVS opts to exclusively offer Gilead's pricey hepatitis C drugRead the original story w/Photo

    Jan 5, 2015 | Business Journal

    Gilead Sciences Inc. , whose stock plummeted last month when Express Scripts Holding Co. chose to offer a competitor's hepatitis C drug, jumped Monday after CVS Health Corp. said Gilead's pill would be offered exclusively to patients on its drug benefit plans.


  3. Stocks Lose More Ground; Gilead Sciences RisesRead the original story w/Photo

    Jan 5, 2015 | Investor's Business Daily

    Stocks slid to fresh session lows late Monday as oil prices continued to weigh. West Texas Intermediate closed at $50.04 a barrel, down 5%.


  4. CVS offers prescription labels for visually impairedRead the original story

    Jan 5, 2015 | Chain Store Age

    CVS Health now offers the ScriptAbility prescription accessibility system through its mail service pharmacy to CVS/Caremark members who are blind or visually impaired. The system includes ScripTalk talking prescription labels, as well as braille and large print labels.


  5. Kentucky getting ready to switch insurance contractorsRead the original story w/Photo

    Dec 31, 2014 | Business Journal

    Anthem Inc. is the state's new medical benefit vendor starting in 2015. That contract previously was held by Louisville-based Humana Inc. Earlier this year, the state wrapped up a request for proposals process that sought vendors to administer benefits, Crystal Staley , executive director of the Kentucky Personnel Cabinet, told me in an email.


  6. A Dozen Stocks To Buy And Hold For 2015Read the original story w/Photo

    Dec 30, 2014 |

    ... that I am confident will be the super achievers in the new year. They are: Apple (AAPL), Bank of America (BAC), CVS Caremark (CVS), Facebook (FB), Google Class A (GOOGL), Home Depot (HD), Microsoft (MFST), Pfizer (PFE), TJX Cos. (TJX), UnitedHealth ...


  7. One Reason Rite Aid Could Soar HigherRead the original story w/Photo

    Dec 28, 2014 | Seeking Alpha

    Even after such a high share price appreciation, however, there could be additional upside given a major industry shift that's taking place. As the smallest player in the industry, this could present Rite Aid with attractive upside, but investors should also consider that Walgreen and CVS Caremark could benefit even more.


  8. Pharma Stocks Could Be in Deep Trouble in 2015. Here's Why.Read the original story w/Photo

    Dec 28, 2014 | The Motley Fool

    ... need to accept that this payer pushback against pricey new drugs is rapidly becoming an industrywide issue. CVS Caremark, ) excluded a whopping 95 brand-name drugs from its formulary for 2015, and said this list could grow to 200 in the final ...


  9. 2015: the year businesses recognize that climate change is realRead the original story

    Dec 26, 2014 | Canadian Content

    ... Unilever set ever more aggressive and inclusive goals and created marketing plans to persuade others to join. CVS Caremark disrupted its sector by announcing that it would stop selling tobacco and would rebrand itself as CVS Health to better align ...


  10. Walgreen Q1 Earnings Top On Strong Prescription SalesRead the original story w/Photo

    Dec 23, 2014 | Investor's Business Daily

    On Tuesday, the drugstore chain reported a 12.5% increase in earnings to 81 cents per share. Analysts polled by Thomson Reuters were expecting 75 cents.


  11. Rite Aid After Earnings: Alive To Fight Another DayRead the original story w/Photo

    Dec 22, 2014 | Seeking Alpha

    ... Reducing the debt load would reduce the company's interest expense and bolster earnings. CVS Health (formerly CVS Caremark) recently ceased sales of all tobacco products in an attempt to change the company's image and appeal. However, they left a ...


  12. Bitter pill: Drugs work but drive overall costRead the original story w/Photo

    Dec 22, 2014 | The Times-Tribune

    ... of filling a specialty drug prescription for one month is $1,800 compared to $54 for other prescription drugs. CVS Caremark also projects that the costs of the entire specialty drug market will reach $402 billion by 2020. Thanks to advanced ...


  13. AbbVie's Hep C Regimen OK'd, 12-Week Cost $83,319Read the original story

    Dec 19, 2014 | Investor's Business Daily

    AbbVie's hepatitis C regimen won FDA approval Friday, becoming the second entrant in what is already a huge market for interferon-free HCV treatments. The Viekira Pak will cost $83,319 for 12 weeks, in line with forecasts and undercutting Gilead Sciences' $94,500 for the same treatment length.


  14. Amid war on drug costs, consumers win and loseRead the original story w/Photo

    Dec 15, 2014 | Bank Rate

    ... largest pharmacy benefit manager, slashed 48 drugs from its 2014 national formulary, while its closest rival, CVS Caremark, dropped around 30 drugs in 2012 and another 70 or so this year. Pharmacy benefit managers are using exclusion to offset the ...


  15. Stock Market Today: Crude Oil, Ruble Sink StocksRead the original story w/Photo

    Dec 16, 2014 | Investor's Business Daily

    Major averages ended near session lows after a volatile session Wednesday that started with sliding oil prices and news before the open from Russia. The Nasdaq sank 1.2%, the S&P 500 fell 0.8% and the Dow Jones industrial average gave up 0.7%.


  16. CVS Health Scores New High, But Most Stocks Pull BackRead the original story w/Photo

    Dec 16, 2014 | Investor's Business Daily

    Some stocks rose to new highs Tuesday, but many pulled back with the broader market and energy once again led the new-lows list. rose 2.44, or 3%, to a new high of 92.31 in double its usual trade.


  17. DJIA Today: Another Volatile Session Ends on Triple-Digit LossRead the original story w/Photo

    Dec 16, 2014 | Money Morning

    Biotech Insider Alert tracks the most crucial milestones in a new drug or medical technology's journey to the marketplace - and shows you how to invest for maximum gains. This fast-paced technical trading service shows regular investors how to profit just like pros - taking big, reliable gains quickly, over and over, with minimal risk.


  18. Stocks Rebound Strongly; Monster, Alibaba RallyRead the original story w/Photo

    Dec 16, 2014 | Investor's Business Daily

    The Dow led in the stock market today , climbing 1.2%. The S&P 500 added 1.1% and the Nasdaq was up 0.7%.


  19. CVS Shares Up On Guidance, Dividend, Share BuybackRead the original story w/Photo

    Dec 16, 2014 | Investor's Business Daily

    CVS said that it would raise its quarterly cash dividend 27% to $0.35 a share, payable Feb. 2 to stockholders of record on Jan. 22. The company added that its stock repurchase plan, which covers as much as $10 billion in shares, is in effect now and will be completed over a multiyear period. on Monday announced a 25% hike in its quarterly dividend and widened its share repurchase program to a company-record $12 billion, Bloomberg said.


  20. Buzz Stocks: BlackBerry Ltd, CVS Health Corp, and Talisman Energy Inc.Read the original story

    Dec 16, 2014 |

    Intensifying fears about the future of Russia's economy are pressuring U.S. futures lower this morning. In company news, today's stocks to watch include handset maker BlackBerry Ltd , pharmacy chain CVS Health Corp , and oil-and-gas producer Talisman Energy Inc. .